<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04595058</url>
  </required_header>
  <id_info>
    <org_study_id>BAMPI</org_study_id>
    <nct_id>NCT04595058</nct_id>
  </id_info>
  <brief_title>LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent</brief_title>
  <acronym>BAMPI</acronym>
  <official_title>Multicenter, Randomized and Comparative Study of Lumen-apposing Metal Stents With or Without Coaxial Plastic Stent for Endoscopic Ultrasound-guided Transmural Biliary Drainage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Mutua de Terrassa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital del Río Hortega</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clínico Universitario de Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital General Universitario de Alicante</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Provincial de Castellon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari de Bellvitge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate technical, clinical and safety outcomes of lumen-apposing&#xD;
      metal stent (LAMS) with and without a coaxial double-pigtail plastic stent (DPS) in&#xD;
      EUS-guided choledochoduodenostomies (CDS) for the management of biliary obstruction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The introduction of specific biliary lumen-apposing metal stents (LAMS) represented a great&#xD;
      technical improvement in EUS-guided transmural Biliary drainage (BD) of distal malignant&#xD;
      biliary obstruction Data is still limited, but recent studies and reviews have been reported&#xD;
      with acceptable technical and clinical success. However, some concerns exist regarding its&#xD;
      safety, as secondary adverse events&#xD;
&#xD;
      There are doubts concerning the possible benefits derived from the insertion of&#xD;
      double-pigtail plastic stents (DPS) within the lumen-apposing metal stents (LAMS) in the&#xD;
      EUS-guided choledochoduodenostomy (CDS). Our hypothesis is that adding a coaxial plastic&#xD;
      stent may offer benefits in terms of safety in CDS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 17, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety (Adverse events)</measure>
    <time_frame>12 months</time_frame>
    <description>Safety will be measured by careful and comparative evaluation of adverse effects in both groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrent biliary obstruction (RBO)</measure>
    <time_frame>12 months</time_frame>
    <description>Recurrent biliary obstruction (RBO) has been defined as a composite endpoint of either occlusion or migration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical success</measure>
    <time_frame>2 weeks</time_frame>
    <description>Resolution of jaundice or drop in total bilirubin level by &gt; 50% within 2 weeks after the EUS-CD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>24 hours.</time_frame>
    <description>Technical success was defined as successful placement of the LAMS between the bile duct and the duodenal lumen, creating a transmural ostomy. To evaluate the correct position of the transmural stent, the deployment of the internal flap in the lumen of the bile duct must be verified by ultrasound vision and the internal flap by endoscopic vision.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>12 months</time_frame>
    <description>Survival is defined as the time elapsed between biliary drainage and the end of follow-up, either due to death and cessation of follow-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Biliary Obstruction</condition>
  <condition>Pancreatic Cancer</condition>
  <condition>Biliary Tract Neoplasms</condition>
  <arm_group>
    <arm_group_label>EUSDB-LAMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stent . Formal indication on biliopancreatic drainage according to the instruction forms of the manufacturer.&#xD;
EUSDB-LAMS (Endoscopic ultrasound guided biliary drainage with lumen-apposing metal stent)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EUSDB-LAMS-Pigtail</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stents without coaxial plastic stent. Formal indication on biliopancreatic drainage according to the instruction forms of the manufacturer.&#xD;
In this arm, a double pigtail through the lumen apposing metal stent will be inserted as an axis-orienting stent.&#xD;
EUSDB-LAMS-Pigtial (Endoscopic ultrasound guided biliary drainage with lumen-apposing metal stent (LAMS) and axis-orienting double-pigtail plastic stent through LAMS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double pigtail plastic stent through lumen-apposing metal stent</intervention_name>
    <description>Biliary drainage guided by endoscopic ultrasound: Addition or not, of a axis-orienting plastic stent, mostly, double-pigtail stent through the lumen of a lumen-apposing metal stent</description>
    <arm_group_label>EUSDB-LAMS-Pigtail</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lumen-apposing metal stent without double pigtail plastic stent</intervention_name>
    <description>Endoscopic ultrasound-guided transmural biliary drainage is with lumen-apposing metal stent is a formal indication according to the instruction forms of the manufacturer.</description>
    <arm_group_label>EUSDB-LAMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Distal biliary strictures,&#xD;
&#xD;
          -  A prior failed attempt at biliary drainage&#xD;
&#xD;
          -  informed consent provided by the patient.&#xD;
&#xD;
        Patient exclusion criteria were as follows:&#xD;
&#xD;
          -  younger than age 18 years,&#xD;
&#xD;
          -  coagulopathy (international normalized ratio &gt;1.5, marked thrombocytopenia with a&#xD;
             platelet count &lt;50,000/mL, or patient on anticoagulation therapy),&#xD;
&#xD;
          -  critical illness.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albert Garcia-Sumalla, MD</last_name>
    <phone>+34676713146</phone>
    <email>albertg.sumalla@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona, Catalonia</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan B Gornals, MD, PhD</last_name>
      <phone>+34 93 260 76 82</phone>
      <phone_ext>2624</phone_ext>
      <email>jgornals@bellvitgehospital.cat</email>
    </contact>
    <contact_backup>
      <last_name>Albert Garcia-Sumalla, MD</last_name>
      <phone>+34 676713146</phone>
      <phone_ext>2624</phone_ext>
      <email>albertg.sumalla@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Albert Garcia-Sumalla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergi Bazaga Pérez de Rozas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Gornals, MD, PhD</last_name>
      <phone>+ 34 93 260 7682</phone>
      <phone_ext>2624</phone_ext>
      <email>jgornals@bellvitgehospital.cat</email>
    </contact>
    <investigator>
      <last_name>Albert Garcia-Sumalla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Anderloni A, Fugazza A, Troncone E, Auriemma F, Carrara S, Semeraro R, Maselli R, Di Leo M, D'Amico F, Sethi A, Repici A. Single-stage EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction. Gastrointest Endosc. 2019 Jan;89(1):69-76. doi: 10.1016/j.gie.2018.08.047. Epub 2018 Sep 4.</citation>
    <PMID>30189198</PMID>
  </reference>
  <results_reference>
    <citation>El Chafic AH, Shah JN, Hamerski C, Binmoeller KF, Irani S, James TW, Baron TH, Nieto J, Romero RV, Evans JA, Kahaleh M. EUS-Guided Choledochoduodenostomy for Distal Malignant Biliary Obstruction Using Electrocautery-Enhanced Lumen-Apposing Metal Stents: First US, Multicenter Experience. Dig Dis Sci. 2019 Nov;64(11):3321-3327. doi: 10.1007/s10620-019-05688-2. Epub 2019 Jun 7.</citation>
    <PMID>31175495</PMID>
  </results_reference>
  <results_reference>
    <citation>Jacques J, Privat J, Pinard F, Fumex F, Chaput U, Valats JC, Cholet F, Jezequel J, Grandval P, Legros R, Lepetit H, Albouys J, Napoleon B. EUS-guided choledochoduodenostomy by use of electrocautery-enhanced lumen-apposing metal stents: a French multicenter study after implementation of the technique (with video). Gastrointest Endosc. 2020 Jul;92(1):134-141. doi: 10.1016/j.gie.2020.01.055. Epub 2020 Feb 19.</citation>
    <PMID>32084411</PMID>
  </results_reference>
  <results_reference>
    <citation>Tsuchiya T, Teoh AYB, Itoi T, Yamao K, Hara K, Nakai Y, Isayama H, Kitano M. Long-term outcomes of EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction: a prospective multicenter study. Gastrointest Endosc. 2018 Apr;87(4):1138-1146. doi: 10.1016/j.gie.2017.08.017. Epub 2017 Aug 24.</citation>
    <PMID>28843583</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>October 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Joan B Gornals</investigator_full_name>
    <investigator_title>Head of Interventional Digestive Endoscopy Unit.</investigator_title>
  </responsible_party>
  <keyword>Choledochoduodenostomy;</keyword>
  <keyword>Therapeutic endoscopy</keyword>
  <keyword>lumen apposing metal stent</keyword>
  <keyword>biliary drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

